Merck & Co., Inc. - MRK Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $125.14
  • Forecasted Upside: 20.47%
  • Number of Analysts: 21
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 16 Buy Ratings
  • 0 Strong Buy Ratings
▼ -1.75 (-1.66%)

This chart shows the closing price for MRK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Merck & Co., Inc. Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MRK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MRK

Analyst Price Target is $125.14
▲ +20.47% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Merck & Co., Inc. in the last 3 months. The average price target is $125.14, with a high forecast of $135.00 and a low forecast of $115.00. The average price target represents a 20.47% upside from the last price of $103.88.

This chart shows the closing price for MRK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Moderate Buy

The current consensus among 21 contributing investment analysts is to moderate buy stock in Merck & Co., Inc.. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/29/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
11/15/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
11/9/2023Deutsche Bank AktiengesellschaftInitiated CoverageBuy$115.00Low
10/27/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$115.00 ➝ $118.00Low
10/27/2023BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$132.00Low
10/23/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
10/20/2023UBS GroupUpgradeNeutral ➝ Buy$117.00 ➝ $122.00Low
10/11/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$116.00 ➝ $115.00Low
10/6/2023Truist FinancialReiterated RatingBuy ➝ Buy$122.00Low
10/2/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
9/5/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
8/22/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00Low
8/2/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$109.00 ➝ $116.00N/A
8/2/2023Truist FinancialBoost TargetBuy ➝ Buy$116.00 ➝ $122.00Low
7/20/2023Truist FinancialLower TargetBuy$118.00 ➝ $116.00Low
7/18/2023BMO Capital MarketsBoost Target$102.00 ➝ $113.00Low
7/14/2023HSBCInitiated CoverageHold$123.00Low
5/1/2023BarclaysBoost Target$128.00 ➝ $130.00Low
4/16/2023BTIG ResearchDowngradeBuy ➝ NeutralLow
4/13/2023CitigroupUpgradeNeutral ➝ Buy$105.00 ➝ $130.00Low
4/11/2023GuggenheimBoost TargetBuy$123.00 ➝ $124.00Low
4/10/2023MizuhoReiterated RatingBuy$130.00Low
3/28/2023Societe GeneraleDowngradeBuy ➝ HoldLow
3/17/2023MizuhoReiterated RatingBuy$130.00Low
3/13/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$120.00 ➝ $115.00Low
3/10/2023Berenberg BankBoost TargetBuy$125.00 ➝ $130.00Low
3/9/2023GuggenheimBoost Target$116.00 ➝ $123.00Low
3/7/2023Atlantic SecuritiesBoost TargetOverweight$122.00 ➝ $127.00Low
3/7/2023Credit Suisse GroupBoost TargetOutperform$125.00 ➝ $126.00Low
3/7/2023MizuhoInitiated CoverageBuy$130.00Low
3/6/2023Jefferies Financial GroupInitiated CoverageBuy$125.00Low
2/23/2023JPMorgan Chase & Co.Boost TargetOverweight$120.00 ➝ $125.00Low
2/22/2023Wolfe ResearchUpgradePeer Perform ➝ Outperform$127.00Low
2/13/2023Credit Suisse GroupBoost TargetOutperform$120.00 ➝ $125.00Low
2/3/2023Wells Fargo & CompanyLower TargetOverweight$125.00 ➝ $120.00Low
2/3/2023Morgan StanleyLower TargetEqual Weight$100.00 ➝ $99.00Low
2/3/2023SVB LeerinkBoost TargetOutperform$120.00 ➝ $122.00Low
2/3/2023Truist FinancialBoost TargetBuy$106.00 ➝ $118.00N/A
1/23/2023SVB LeerinkBoost TargetOutperform$112.00 ➝ $120.00Low
1/4/2023Bank of AmericaUpgradeNeutral ➝ Buy$110.00 ➝ $130.00Low
1/3/2023Wells Fargo & CompanyBoost TargetOverweight$110.00 ➝ $125.00Low
1/3/2023CowenBoost Target$108.00 ➝ $120.00Low
12/20/2022BarclaysBoost Target$110.00 ➝ $128.00Low
12/19/2022Cantor FitzgeraldBoost TargetOverweight$120.00 ➝ $135.00Low
12/15/2022MizuhoBoost Target$100.00 ➝ $130.00Low
11/17/2022Credit Suisse GroupInitiated CoverageOutperform$120.00Low
11/15/2022CitigroupBoost Target$105.00Low
11/1/2022GuggenheimBoost TargetBuy$104.00 ➝ $111.00Low
10/28/2022BarclaysBoost TargetOverweight$105.00 ➝ $110.00Low
10/28/2022Wells Fargo & CompanyBoost TargetOverweight$105.00 ➝ $110.00Low
10/28/2022Truist FinancialBoost TargetBuy$103.00 ➝ $106.00Low
10/28/2022SVB LeerinkBoost TargetOutperform$110.00 ➝ $112.00Low
10/28/2022Morgan StanleyBoost TargetEqual Weight$91.00 ➝ $100.00Low
10/28/2022Cantor FitzgeraldBoost Target$107.00 ➝ $120.00Low
10/28/2022Atlantic SecuritiesBoost TargetOverweight$116.00 ➝ $122.00Low
10/12/2022Morgan StanleyLower TargetEqual Weight$92.00 ➝ $91.00Low
10/12/2022BarclaysBoost Target$101.00 ➝ $105.00Low
10/11/2022Atlantic SecuritiesBoost TargetOverweight$110.00 ➝ $116.00Low
10/11/2022Truist FinancialBoost Target$95.00 ➝ $103.00Low
10/10/2022GuggenheimUpgradeNeutral ➝ Buy$104.00Low
9/30/2022SVB LeerinkBoost TargetOutperform$109.00 ➝ $110.00Low
9/14/2022Berenberg BankUpgradeHold ➝ Buy$95.00 ➝ $100.00Low
9/12/2022SVB LeerinkBoost TargetOutperform$105.00 ➝ $109.00Low
8/25/2022Erste Group BankUpgradeHold ➝ BuyLow
7/29/2022Morgan StanleyBoost TargetEqual Weight$88.00 ➝ $92.00Low
7/18/2022UBS GroupBoost TargetNeutral$76.00 ➝ $98.00Low
7/13/2022Atlantic SecuritiesBoost TargetOverweight$105.00 ➝ $110.00N/A
7/8/2022Morgan StanleyBoost TargetEqual Weight$87.00 ➝ $88.00N/A
7/6/2022Daiwa Capital MarketsUpgradeNeutral ➝ Buy$89.00 ➝ $102.00N/A
6/27/2022CowenBoost TargetMarket Perform$95.00 ➝ $102.00Low
6/27/2022CowenBoost TargetMarket Perform$95.00 ➝ $102.00Low
6/24/2022MizuhoInitiated CoverageBuy$100.00Low
6/6/2022SVB LeerinkReiterated RatingOutperform$102.00Low
4/21/2022SVB LeerinkLower TargetOutperform$100.00 ➝ $97.00Low
4/12/2022BarclaysBoost TargetOverweight$94.00 ➝ $97.00Medium
4/6/2022Morgan StanleyLower TargetEqual Weight$82.00 ➝ $80.00Low
4/6/2022SVB LeerinkLower TargetOutperform$101.00 ➝ $100.00Medium
4/1/2022MizuhoInitiated CoverageBuy$100.00Medium
2/4/2022SVB LeerinkLower TargetOutperform$102.00 ➝ $101.00Medium
1/28/2022JPMorgan Chase & Co.Lower TargetOverweight$100.00 ➝ $95.00Low
12/23/2021MizuhoInitiated CoverageBuy$100.00Low
12/17/2021The Goldman Sachs GroupInitiated CoverageConviction-Buy$93.00High
12/16/2021Daiwa Capital MarketsInitiated CoverageNeutral$70.00Medium
12/13/2021MizuhoReiterated RatingBuyHigh
12/13/2021UBS GroupDowngradeBuy ➝ Neutral$98.00 ➝ $76.00High
12/8/2021Wells Fargo & CompanyInitiated CoverageOverweight$90.00Low
12/7/2021GuggenheimDowngradeBuy ➝ Neutral$98.00Low
11/30/2021SVB LeerinkReiterated RatingBuyLow
11/29/2021Morgan StanleyLower TargetSell ➝ Equal Weight$88.00 ➝ $82.00High
11/29/2021CitigroupDowngradeBuy ➝ Neutral$105.00 ➝ $85.00High
11/24/2021Truist FinancialBoost TargetBuy$92.00 ➝ $95.00Low
11/18/2021BMO Capital MarketsInitiated CoverageMarket Perform$91.00High
11/1/2021BarclaysBoost TargetOverweight$92.00 ➝ $94.00Low
11/1/2021ArgusUpgradeHold ➝ Buy$110.00Low
10/29/2021Morgan StanleyBoost TargetEqual Weight$88.00 ➝ $90.00Low
10/28/2021MizuhoInitiated CoverageBuy$99.00High
10/22/2021SVB LeerinkBoost TargetOutperform$104.00 ➝ $105.00Low
10/12/2021Morgan StanleyBoost TargetEqual Weight$85.00 ➝ $88.00Medium
10/10/2021Berenberg BankReiterated RatingHold$86.00 ➝ $92.00Low
10/8/2021BarclaysBoost TargetOverweight$87.00 ➝ $92.00Low
10/4/2021SVB LeerinkBoost TargetOutperform$101.00 ➝ $104.00Medium
10/1/2021MizuhoInitiated CoverageBuy$100.00High
9/7/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$90.00 ➝ $85.00High
7/30/2021SVB LeerinkBoost TargetOutperform$99.00 ➝ $101.00Low
7/27/2021Truist FinancialInitiated CoverageBuy$76.79Low
6/9/2021JPMorgan Chase & Co.Lower TargetOverweight$105.00 ➝ $100.00Medium
6/7/2021Truist FinancialLower TargetBuy$96.00 ➝ $93.00High
6/3/2021SVB LeerinkLower TargetOutperform$102.00 ➝ $99.00Medium
5/20/2021ArgusReiterated RatingBuy ➝ HoldMedium
4/30/2021SVB LeerinkLower TargetOutperform$103.00 ➝ $102.00Low
2/5/2021Cantor FitzgeraldReiterated RatingOverweightMedium
12/6/2020MizuhoReiterated RatingBuy$100.00Low
11/10/2020Sanford C. BernsteinReiterated RatingOutperform$95.00Low
11/4/2020JPMorgan Chase & Co.Set TargetNeutral€130.00N/A
10/30/2020The Goldman Sachs GroupSet TargetSell€102.00N/A
10/29/2020SVB LeerinkBoost TargetOutperform$100.00 ➝ $103.00Low
10/28/2020Kepler Capital MarketsSet TargetBuy€144.00N/A
10/27/2020JPMorgan Chase & Co.Set TargetNeutral€130.00N/A
10/23/2020Truist FinancialInitiated CoverageBuy$96.00Low
10/21/2020Morgan StanleySet TargetNeutral€127.00N/A
10/21/2020Sanford C. BernsteinSet TargetNeutral€135.00N/A
10/16/2020JPMorgan Chase & Co.Boost TargetOverweight$98.00 ➝ $105.00Low
10/13/2020BarclaysSet TargetNeutral€125.00N/A
10/1/2020Independent ResearchSet TargetBuy€139.00N/A
9/29/2020Berenberg BankInitiated CoverageHold$88.00Medium
9/28/2020DZ BankReiterated RatingBuyN/A
9/28/2020The Goldman Sachs GroupSet TargetSell€102.00N/A
9/22/2020MizuhoReiterated RatingBuyLow
9/22/2020The Goldman Sachs GroupSet TargetSell€100.00N/A
9/21/2020JPMorgan Chase & Co.Set TargetNeutral€130.00N/A
9/18/2020Independent ResearchSet TargetBuy€138.00N/A
9/17/2020Credit Suisse GroupSet TargetBuy€140.00N/A
9/16/2020Sanford C. BernsteinSet TargetNeutral€115.00N/A
9/16/2020The Goldman Sachs GroupSet TargetSell€100.00N/A
9/15/2020JPMorgan Chase & Co.Set TargetNeutral€130.00N/A
9/14/2020Morgan StanleySet TargetNeutral€127.00N/A
8/27/2020Kepler Capital MarketsSet TargetBuy€130.00N/A
8/25/2020SVB LeerinkBoost TargetOutperform$95.00 ➝ $100.00Low
8/24/2020The Goldman Sachs GroupSet TargetSell€100.00N/A
8/10/2020DZ BankReiterated RatingBuyN/A
8/7/2020Independent ResearchSet TargetBuy€124.00N/A
8/7/2020Kepler Capital MarketsSet TargetBuy€130.00N/A
8/7/2020UBS GroupSet TargetNeutral€108.00N/A
8/7/2020Sanford C. BernsteinSet TargetNeutral€115.00N/A
8/7/2020Credit Suisse GroupSet TargetBuy€125.00N/A
8/7/2020BarclaysSet TargetSell€92.00N/A
8/6/2020Warburg ResearchSet TargetNeutral€108.00N/A
8/6/2020Nord/LBSet TargetNeutral€108.00N/A
8/6/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00N/A
8/6/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
8/6/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
8/4/2020Royal Bank of CanadaReiterated RatingHoldMedium
8/3/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$91.00 ➝ $105.00High
7/31/2020MizuhoReiterated RatingBuy$100.00Low
7/29/2020Warburg ResearchSet TargetNeutral€108.00N/A
7/29/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
7/28/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
7/23/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
7/22/2020DZ BankReiterated RatingBuyN/A
7/22/2020Credit Suisse GroupSet TargetBuy€125.00N/A
7/21/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
7/7/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
7/1/2020Kepler Capital MarketsSet TargetSell€122.00N/A
6/23/2020MizuhoReiterated RatingBuy$100.00Medium
6/23/2020Morgan StanleyReiterated RatingBuy$89.00Medium
6/12/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformMedium
6/10/2020Kepler Capital MarketsSet TargetBuy€122.00N/A
6/10/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
6/8/2020Sanford C. BernsteinSet TargetNeutral€115.00N/A
6/4/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
6/3/2020BarclaysSet TargetSell€90.00N/A
6/2/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
5/29/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
5/27/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
5/21/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00N/A
5/19/2020DZ BankReiterated RatingBuyN/A
5/18/2020HSBCSet TargetNeutral€101.00N/A
5/15/2020BarclaysSet TargetSell€90.00N/A
5/15/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00N/A
5/15/2020Credit Suisse GroupSet TargetBuy€125.00N/A
5/15/2020Independent ResearchSet TargetBuy€122.00N/A
5/15/2020Nord/LBSet TargetNeutral€110.00N/A
5/14/2020Sanford C. BernsteinSet TargetNeutral€113.00N/A
5/14/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
5/14/2020UBS GroupSet TargetNeutral€108.00N/A
5/14/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
5/14/2020Warburg ResearchSet TargetNeutral€106.00N/A
5/7/2020Warburg ResearchSet TargetNeutral€106.00N/A
5/5/2020Kepler Capital MarketsSet TargetBuy€122.00N/A
5/5/2020BarclaysSet TargetSell€90.00N/A
5/5/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00N/A
5/5/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
5/5/2020Credit Suisse GroupSet TargetBuy€125.00N/A
5/4/2020DZ BankReiterated RatingBuyN/A
5/4/2020Credit Suisse GroupReiterated RatingBuy$95.00Low
5/1/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
4/29/2020GuggenheimLower TargetBuy$101.00 ➝ $93.00Low
4/29/2020BarclaysLower TargetOverweight$93.00 ➝ $90.00Low
4/29/2020SVB LeerinkLower TargetOutperform$98.00 ➝ $95.00Low
4/16/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
4/15/2020Sanford C. BernsteinSet TargetNeutral€113.00N/A
4/13/2020UBS GroupLower TargetBuy$96.00 ➝ $92.00Low
4/7/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
4/2/2020Morgan StanleyLower TargetOverweight$97.00 ➝ $89.00Medium
4/1/2020Royal Bank of CanadaLower TargetSector Perform$92.00 ➝ $89.00Low
3/24/2020ArgusLower TargetBuy$105.00 ➝ $95.00Low
3/19/2020Nord/LBSet TargetBuy€98.00N/A
3/16/2020DZ BankReiterated RatingBuyN/A
3/13/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
3/9/2020Independent ResearchSet TargetBuy€128.00N/A
3/9/2020UBS GroupSet TargetNeutral€108.00N/A
3/6/2020Credit Suisse GroupSet TargetBuy€125.00N/A
3/5/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
3/5/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
3/5/2020Sanford C. BernsteinSet TargetNeutral€120.00N/A
3/5/2020BarclaysSet TargetSell€94.00N/A
3/4/2020Kepler Capital MarketsSet TargetBuy€119.00N/A
3/2/2020UBS GroupSet TargetNeutral€108.00N/A
2/27/2020BarclaysInitiated CoverageOverweight$93.00Medium
2/20/2020Credit Suisse GroupSet TargetBuy€125.00N/A
2/18/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€115.00N/A
2/10/2020DZ BankReiterated RatingBuyN/A
2/10/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
2/6/2020Royal Bank of CanadaReiterated RatingSector Perform$92.00Low
2/6/2020UBS GroupLower TargetBuy$99.00 ➝ $96.00Low
2/5/2020MizuhoReiterated RatingBuyHigh
2/5/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
1/28/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
1/23/2020UBS GroupBoost TargetBuy$94.00 ➝ $99.00Low
1/21/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
1/21/2020Nord/LBSet TargetNeutral€110.00N/A
1/20/2020BarclaysSet TargetSell€94.00N/A
1/16/2020Credit Suisse GroupSet TargetBuy€125.00N/A
1/8/2020Cantor FitzgeraldReiterated RatingBuy$95.00Medium
1/6/2020MizuhoReiterated RatingBuy$100.00High
1/6/2020Royal Bank of CanadaInitiated CoverageSector Perform$99.00High
1/6/2020JPMorgan Chase & Co.Set TargetNeutral€110.00N/A
1/6/2020Sanford C. BernsteinSet TargetNeutral€120.00N/A
1/6/2020BarclaysSet TargetSell€88.00N/A
1/2/2020The Goldman Sachs GroupSet TargetSell€94.00N/A
12/31/2019BarclaysSet TargetSell€88.00N/A
12/25/2019BarclaysSet TargetSell€88.00N/A
12/19/2019BarclaysSet TargetSell€88.00N/A
12/9/2019The Goldman Sachs GroupSet TargetSell€94.00N/A
12/6/2019JPMorgan Chase & Co.Set TargetNeutral€104.00N/A
12/3/2019The Goldman Sachs GroupSet TargetSell€94.00N/A
11/27/2019HSBCSet TargetNeutral€96.00N/A
11/26/2019UBS GroupSet TargetNeutral€104.00N/A
11/22/2019DZ BankReiterated RatingBuyN/A
11/19/2019Nord/LBSet TargetNeutral€110.00N/A
11/19/2019JPMorgan Chase & Co.Set TargetNeutral€104.00N/A
11/18/2019BarclaysSet TargetSell€85.00N/A
11/18/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€104.00N/A
11/15/2019Credit Suisse GroupSet TargetBuy€110.00N/A
11/14/2019Sanford C. BernsteinSet TargetNeutral€114.00N/A
11/14/2019UBS GroupSet TargetNeutral€96.00N/A
11/13/2019Morgan StanleyBoost TargetOverweight$90.00 ➝ $95.00Low
11/13/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
11/12/2019BarclaysSet TargetSell€85.00N/A
11/12/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€104.00N/A
11/11/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
11/4/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
10/30/2019MizuhoBoost TargetBuy$97.00 ➝ $100.00Medium
10/18/2019MizuhoReiterated RatingBuy$97.00Low
10/16/2019Bank of AmericaInitiated CoverageNeutral$90.00Low
10/14/2019BarclaysSet TargetSell€82.00N/A
10/10/2019JPMorgan Chase & Co.Set TargetBuy$96.00Low
10/9/2019Sanford C. BernsteinSet TargetNeutral€114.00N/A
10/4/2019Nord/LBSet TargetNeutral€94.00N/A
9/19/2019Independent ResearchSet TargetNeutral€103.00N/A
9/13/2019Bank of AmericaSet TargetNeutral€110.00N/A
9/12/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
9/12/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
9/10/2019Morgan StanleySet TargetNeutral€96.00N/A
9/8/2019MizuhoReiterated RatingBuy$97.00High
9/6/2019Credit Suisse GroupSet TargetBuy€110.00N/A
9/3/2019Societe GeneraleSet TargetBuy$105.00Low
8/16/2019SVB LeerinkInitiated CoverageOutperform ➝ Outperform$103.00Low
8/15/2019HSBCSet TargetNeutral€96.00N/A
8/14/2019DZ BankReiterated RatingBuyN/A
8/14/2019BarclaysSet TargetSell€82.00N/A
8/9/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€96.00N/A
8/9/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
8/9/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
8/9/2019Independent ResearchSet TargetNeutral€102.00N/A
8/9/2019Nord/LBSet TargetNeutral€94.00N/A
8/8/2019Credit Suisse GroupSet TargetBuy€110.00N/A
8/8/2019UBS GroupSet TargetNeutral€99.00N/A
8/7/2019Credit Suisse GroupReiterated RatingBuy$95.00Low
8/7/2019ArgusBoost TargetHold ➝ Buy$105.00Low
8/5/2019MizuhoReiterated RatingBuy$97.00Low
7/30/2019Warburg ResearchSet TargetNeutral€103.00N/A
7/23/2019DZ BankReiterated RatingBuyN/A
7/11/2019Credit Suisse GroupInitiated CoverageBuy$95.00Low
7/11/2019Bank of AmericaSet TargetBuy$97.00High
7/2/2019MizuhoInitiated CoverageBuy ➝ Buy$97.00Low
7/1/2019Credit Suisse GroupSet TargetBuy€110.00N/A
6/21/2019Bank of AmericaBoost TargetBuy$91.00 ➝ $96.00Medium
6/21/2019Morgan StanleyBoost TargetOverweight$84.00 ➝ $90.00Low
6/21/2019CitigroupBoost TargetBuy$84.00 ➝ $95.00Low
6/19/2019Independent ResearchSet TargetNeutral€106.00N/A
6/18/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
6/18/2019Morgan StanleySet TargetNeutral€96.00N/A
6/17/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
6/14/2019JPMorgan Chase & Co.Boost TargetOverweight$90.00 ➝ $93.00Low
6/14/2019Warburg ResearchSet TargetNeutral€103.00N/A
6/4/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
6/4/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
5/28/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$85.00Medium
5/27/2019BarclaysSet TargetSell€82.00N/A
5/22/2019DZ BankReiterated RatingBuyN/A
5/22/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
5/17/2019Morgan StanleySet TargetNeutral€96.00N/A
5/17/2019Nord/LBSet TargetNeutral€94.00N/A
5/16/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€96.00N/A
5/15/2019Credit Suisse GroupSet TargetBuy€110.00N/A
5/14/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
5/14/2019BarclaysSet TargetSell€82.00N/A
5/14/2019Warburg ResearchSet TargetNeutral€103.00N/A
5/14/2019Independent ResearchSet TargetNeutral€106.00N/A
5/14/2019Kepler Capital MarketsSet TargetBuy€110.00N/A
5/13/2019UBS GroupSet TargetNeutral€104.00N/A
5/13/2019Atlantic SecuritiesUpgradeNeutral ➝ OverweightLow
5/13/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
5/9/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€97.00N/A
5/7/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
5/3/2019BarclaysSet TargetSell€82.00N/A
5/2/2019UBS GroupBoost TargetBuy ➝ Buy$87.00 ➝ $88.00Medium
5/1/2019Bank of AmericaBoost TargetBuy ➝ Buy$90.00 ➝ $91.00Low
5/1/2019BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$83.00 ➝ $84.00Low
4/25/2019UBS GroupSet TargetNeutral€104.00N/A
4/16/2019Independent ResearchSet TargetNeutral€103.00N/A
4/16/2019DZ BankReiterated RatingNeutralN/A
4/15/2019Sanford C. BernsteinSet TargetNeutral€108.00N/A
4/12/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
4/9/2019Warburg ResearchSet TargetNeutral€103.00N/A
4/9/2019UBS GroupSet TargetNeutral€108.00N/A
4/8/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
4/8/2019BarclaysSet TargetSell€82.00N/A
4/2/2019DZ BankReiterated RatingNeutralN/A
4/2/2019Warburg ResearchSet TargetNeutral€103.00N/A
4/1/2019Kepler Capital MarketsSet TargetBuy€110.00N/A
4/1/2019UBS GroupSet TargetNeutral€108.00N/A
3/29/2019Cantor FitzgeraldReiterated RatingBuy$95.00Low
3/27/2019Societe GeneraleSet TargetNeutral€105.00N/A
3/27/2019Warburg ResearchSet TargetNeutral€103.00N/A
3/20/2019Warburg ResearchSet TargetNeutral€103.00N/A
3/19/2019DZ BankReiterated RatingNeutralN/A
3/19/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
3/15/2019UBS GroupSet TargetNeutral€108.00N/A
3/14/2019Kepler Capital MarketsSet TargetBuy€110.00N/A
3/11/2019HSBCSet TargetNeutral€96.00N/A
3/11/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€97.00N/A
3/8/2019Credit Suisse GroupSet TargetBuy€110.00N/A
3/7/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
3/7/2019Independent ResearchSet TargetNeutral€100.00N/A
3/7/2019Nord/LBSet TargetNeutral€94.00N/A
3/7/2019UBS GroupSet TargetBuy€115.00N/A
3/7/2019Warburg ResearchSet TargetNeutral€103.00N/A
3/7/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
3/7/2019The Goldman Sachs GroupSet TargetNeutral€95.00N/A
3/4/2019Cantor FitzgeraldReiterated RatingBuy$95.00Low
3/4/2019Deutsche Bank AktiengesellschaftSet TargetNeutral€95.00N/A
3/1/2019Independent ResearchSet TargetNeutral€100.00N/A
2/28/2019Warburg ResearchSet TargetNeutral€103.00N/A
2/28/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
2/28/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
2/27/2019JPMorgan Chase & Co.Reiterated RatingNeutralN/A
2/22/2019Cantor FitzgeraldInitiated CoverageOverweight$95.00Low
2/20/2019ArgusBoost TargetHold ➝ Buy$95.00Low
2/19/2019BMO Capital MarketsReiterated RatingHoldLow
2/18/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
2/12/2019The Goldman Sachs GroupSet TargetNeutral€95.00N/A
2/12/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
2/12/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
2/11/2019Morgan StanleySet TargetNeutral€90.00N/A
2/11/2019DZ BankReiterated RatingNeutralN/A
2/6/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
2/5/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
2/5/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
1/24/2019Kepler Capital MarketsSet TargetBuy€108.00N/A
1/24/2019Nord/LBSet TargetSell€80.00N/A
1/23/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$80.00Low
1/15/2019BarclaysSet TargetSell€78.00N/A
1/15/2019JPMorgan Chase & Co.Reiterated RatingNeutralN/A
1/8/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
1/3/2019Sanford C. BernsteinSet TargetBuy€105.00N/A
1/2/2019JPMorgan Chase & Co.Set TargetNeutral€100.00N/A
12/20/2018CitigroupSet TargetHold$65.00Low
12/20/2018Morgan StanleySet TargetBuy$81.00Medium
12/14/2018Morgan StanleySet TargetNeutral€88.00N/A
12/14/2018Bank of AmericaSet TargetNeutral€105.00N/A
12/13/2018Credit Suisse GroupSet TargetBuy$86.00Low
12/12/2018Kepler Capital MarketsSet TargetBuy€108.00N/A
12/10/2018Deutsche Bank AktiengesellschaftSet TargetNeutral€93.00N/A
12/10/2018Sanford C. BernsteinSet TargetBuy€105.00N/A
(Data available from 12/7/2018 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 31 very positive mentions
  • 47 positive mentions
  • 9 negative mentions
  • 4 very negative mentions
  • 15 very positive mentions
  • 23 positive mentions
  • 4 negative mentions
  • 6 very negative mentions
  • 27 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
  • 23 very positive mentions
  • 23 positive mentions
  • 2 negative mentions
  • 7 very negative mentions
  • 19 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
  • 38 very positive mentions
  • 13 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
  • 25 very positive mentions
  • 19 positive mentions
  • 6 negative mentions
  • 6 very negative mentions
  • 28 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 28 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Merck & Co., Inc. logo
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors, as well as a clinical trial collaboration and supply agreement with Phanes Therapeutics, Inc. to evaluate PT886 in combination with KEYTRUDA for the treatment of claudin 18.2 positive gastric or gastroesophageal junction adenocarcinomas, as well as a development and commercialization agreement with Daiichi Sankyo Company, Limited to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Read More

Today's Range

Now: $103.88
Low: $103.73
High: $105.60

50 Day Range

MA: $102.96
Low: $100.17
High: $106.23

52 Week Range

Now: $103.88
Low: $96.36
High: $119.65


9,053,841 shs

Average Volume

7,594,819 shs

Market Capitalization

$263.23 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Merck & Co., Inc.?

The following Wall Street research analysts have issued research reports on Merck & Co., Inc. in the last twelve months: Atlantic Securities, Bank of America Co., Barclays PLC, Berenberg Bank, BMO Capital Markets, BTIG Research, Cantor Fitzgerald, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Guggenheim, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Societe Generale,, SVB Leerink LLC, TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for MRK.

What is the current price target for Merck & Co., Inc.?

21 Wall Street analysts have set twelve-month price targets for Merck & Co., Inc. in the last year. Their average twelve-month price target is $125.14, suggesting a possible upside of 20.5%. Cantor Fitzgerald has the highest price target set, predicting MRK will reach $135.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $115.00 for Merck & Co., Inc. in the next year.
View the latest price targets for MRK.

What is the current consensus analyst rating for Merck & Co., Inc.?

Merck & Co., Inc. currently has 5 hold ratings and 16 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MRK.

What other companies compete with Merck & Co., Inc.?

Other companies that are similar to Merck & Co., Inc. include AbbVie, Pfizer, Johnson & Johnson, Bristol-Myers Squibb and Zoetis. Learn More about companies similar to Merck & Co., Inc..

How do I contact Merck & Co., Inc.'s investor relations team?

Merck & Co., Inc.'s physical mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The company's listed phone number is (908) 740-4000 and its investor relations email address is investor_rel[email protected]. The official website for Merck & Co., Inc. is Learn More about contacing Merck & Co., Inc. investor relations.